Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
about
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainIs adiposopathy (sick fat) an endocrine disease?Metabolic actions of Rho-kinase in periphery and brainFructose consumption: recent results and their potential implicationsSoluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistanceAVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.Cardiovascular consequences of obese and nonobese obstructive sleep apnea.Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.Association between Indices of Body Composition and Abnormal Metabolic Phenotype in Normal-Weight Chinese Adults.De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury.Utility of transplantation in studying adipocyte biogenesis and functionVisceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.Comparative effectiveness of lifestyle interventions on cardiovascular risk factors among a Dutch overweight working population: a randomized controlled trial.Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.The effects of aquatic exercise on body composition, physical fitness, and vascular compliance of obese elementary students.Circulating levels of inflammatory markers in intrauterine growth restriction.Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness.Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial.Antidiabetic activity of standardized extract of Quassia amara in nicotinamide-streptozotocin-induced diabetic rats.Interaction between physical activity and sleep duration in relation to insulin resistance among non-diabetic Chinese adults.Childhood obesity and obstructive sleep apnea syndrome.Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart StudyFatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin.Global left ventricular performance in non-diabetic non-hypertensive metabolic syndrome adults.Covariation of change in bioavailable testosterone and adiposity in midlife women.Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolismEvaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.Abnormal glucose metabolism in Hispanic parents of children with acanthosis nigricansModerate intensity physical activity prevents increased blood glucose concentrations, fat pad deposition and cardiac action potential prolongation following diet-induced obesity in a juvenile-adolescent rat model.Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.Animal models of eating disordersEffect of phosphorus supplementation on weight gain and waist circumference of overweight/obese adults: a randomized clinical trial.Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay miceInsulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instabilityBlockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity.Insulin sensitivity and regional fat gain in response to overfeeding.The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities.
P2860
Q21561008-4906C24C-3C1B-475D-BD37-9918B026B277Q24655610-72BCC5B1-942E-4C3C-A8D5-B6501BC707EFQ26864028-2E0E6BE2-CA82-438F-AB17-3E343A6C8A88Q27968226-0F494DE2-C51B-4581-8112-76F3FB181003Q28388993-12E03A86-33C9-4611-B884-571718E0B2DDQ33567011-F091CAA4-C003-4966-B614-505DE320E35BQ33582266-ED8FAAF3-C384-45D0-9A1B-7D94F6DC0BD4Q33592719-4A55B049-D79D-454F-B570-D5FAB1A58AF2Q33616158-A4B88212-D25D-45C7-AE92-E004010CD3F9Q33673416-85194A1C-85A7-40EA-8089-4F78386ED5A5Q33678794-4126FD10-EDCB-4B02-850B-6FED5DE38B4BQ33751624-138DC8F2-9996-46C6-901F-D6FA9CBF1AE2Q33801607-DEA78F72-BE87-4303-9301-A36912E12159Q33836874-ACD78C0A-AF9B-437B-A89C-FCC0B342813FQ33933147-AABC58DE-DCA2-4AAE-A3A3-5F3D542BA815Q33960827-DFB919C3-0062-4D65-BF73-54D419CBDB96Q34020506-6FB90B65-4D99-454C-8533-597F44E73A0AQ34139287-20AEA5FE-D62D-4443-9549-34B23290BBCAQ34161391-6BF055A8-B102-4388-949B-8F1BB062D303Q34210729-F35E247A-72EA-403C-893D-8546A3E476ACQ34365605-A1B914EC-3C9A-4426-B12C-2F5E4B38ABADQ34376884-5A293B65-E0D5-4C60-805D-C0B76A0D89DFQ34588932-3B9A80F7-F9DE-4C08-AEE1-9B069528ECC8Q34610542-840DB868-3F93-4EC2-91DD-4DC0203A97DFQ34635085-93D877E3-FE92-4A55-83BB-36E49A677D67Q35027683-D223D9CE-5C68-4065-B08A-E1F1134DA2C3Q35036458-6C0EB693-9021-41DD-BCE9-FBB3EC5B5794Q35098802-6EEDE4FE-E141-4A0E-B489-E88609D23F84Q35597066-507FF073-2D29-49F3-BC5F-1C367A03E872Q35684682-C380112A-3EDC-4C17-BD6B-037497677B0EQ35718369-8912CC0D-668C-4B07-AE0C-2712B21A279DQ35822331-BDC0611B-A251-4A32-95A2-0444C172D8A4Q35844499-5ED6C29D-F885-4F49-8E8F-9096C4AE34EAQ35957173-14524FAB-8862-4DF3-BB3C-FD3475402514Q36526465-8CFE88FA-7660-4C24-800E-AC4839210437Q36604200-70AF8811-628F-4F82-B5F6-5D44A058DD3CQ36741853-1FB31E44-08D9-4F22-B50B-A340AE5D519AQ36756506-C4F11960-B35A-43B4-9BC0-BB0030CA63A9Q37011587-BD84A8B4-B95D-46D7-8F51-5FD76356AED4Q37024780-86758B9E-25EB-4EE1-A9BE-2772736C41FE
P2860
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effect of insulin resistance, ...... disease and diabetes mellitus.
@ast
Effect of insulin resistance, ...... disease and diabetes mellitus.
@en
type
label
Effect of insulin resistance, ...... disease and diabetes mellitus.
@ast
Effect of insulin resistance, ...... disease and diabetes mellitus.
@en
prefLabel
Effect of insulin resistance, ...... disease and diabetes mellitus.
@ast
Effect of insulin resistance, ...... disease and diabetes mellitus.
@en
P1476
Effect of insulin resistance, ...... disease and diabetes mellitus.
@en
P2093
Daniel J Rader
P356
10.1016/J.AMJMED.2007.01.003
P407
P433
P577
2007-03-01T00:00:00Z